AU2804297A - Method of and composition for treating disorders of the skin using vitamin k - Google Patents
Method of and composition for treating disorders of the skin using vitamin kInfo
- Publication number
- AU2804297A AU2804297A AU28042/97A AU2804297A AU2804297A AU 2804297 A AU2804297 A AU 2804297A AU 28042/97 A AU28042/97 A AU 28042/97A AU 2804297 A AU2804297 A AU 2804297A AU 2804297 A AU2804297 A AU 2804297A
- Authority
- AU
- Australia
- Prior art keywords
- vitamin
- skin
- composition
- treating disorders
- disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229940046010 vitamin k Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63606796A | 1996-04-22 | 1996-04-22 | |
| US08636067 | 1996-04-22 | ||
| PCT/US1997/006464 WO1997039746A1 (en) | 1996-04-22 | 1997-04-22 | Method of and composition for treating disorders of the skin using vitamin k |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2804297A true AU2804297A (en) | 1997-11-12 |
Family
ID=24550287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU28042/97A Abandoned AU2804297A (en) | 1996-04-22 | 1997-04-22 | Method of and composition for treating disorders of the skin using vitamin k |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2804297A (en) |
| WO (1) | WO1997039746A1 (en) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5837289A (en) * | 1996-07-23 | 1998-11-17 | Grasela; John C. | Transdermal delivery of medications using a combination of penetration enhancers |
| EP1085859A4 (en) * | 1998-06-11 | 2003-02-26 | Univ New Jersey Med | TREATMENT OF INJURY BY INHIBITION OF ADENOSINE DIPHOSPHATE-RIBOSYL TRANSFERASE |
| KR100355952B1 (en) * | 2000-03-15 | 2002-10-11 | 주식회사 코리아나화장품 | Skin Care Composition Containing Fish Cartilage Extract and Polypeptide Phytonadione |
| WO2002089743A2 (en) * | 2001-05-09 | 2002-11-14 | The Regents Of The University Of Michigan | Use of compositions for treating rosacea |
| US7595378B2 (en) | 2001-06-13 | 2009-09-29 | Genmab A/S | Human monoclonal antibodies to epidermal growth factor receptor (EGFR) |
| US6524606B1 (en) | 2001-11-16 | 2003-02-25 | Ap Pharma, Inc. | Bioerodible polyorthoesters containing amine groups |
| US7365167B2 (en) | 2001-11-26 | 2008-04-29 | Cell Matrix, Inc. | Humanized collagen antibodies and related methods |
| US7390885B2 (en) | 2001-11-26 | 2008-06-24 | Cell Matrix, Inc. | Humanized collagen antibodies and related methods |
| WO2004064798A1 (en) * | 2003-01-20 | 2004-08-05 | Auriga International S.A. | Use of a composition comprising vitamin k1 oxide or a derivative thereof for the treatment and/or the prevention of mammal dermatological lesions |
| EP1442738A1 (en) * | 2003-01-28 | 2004-08-04 | Auriga International S.A. | Dermatological cosmetic composition comprising vitamin K1 oxide |
| DK2218342T3 (en) | 2003-05-27 | 2018-10-22 | Dsm Ip Assets Bv | New nutraceutical compositions and their use |
| ATE492275T1 (en) * | 2005-04-15 | 2011-01-15 | Einstein Coll Med | VITAMIN K FOR PREVENTING AND TREATING SKIN RASH AS A RESULT OF ANTI-EGFR THERAPY |
| US9428582B2 (en) | 2006-07-03 | 2016-08-30 | Genmab A/S | Method of treating rash in patients undergoing anti-EGFR therapy |
| WO2009063485A2 (en) * | 2007-07-24 | 2009-05-22 | Viridis Biopharma Pvt Ltd. | Treatment of human disease conditions and disorders using vitamin k analogues and derivatives |
| US9616127B2 (en) * | 2008-03-11 | 2017-04-11 | Livionex Inc. | Method and topical formulation for treating localized edema |
| US8815953B2 (en) | 2008-03-13 | 2014-08-26 | Spectrum Pharmaceuticals, Inc. | Formulations of vitamin K analogs for topical use |
| SG179064A1 (en) * | 2009-09-14 | 2012-04-27 | Nestec Sa | Nutritional compositions for modulating inflammation including exogenous vitamin k2 |
| WO2023119230A1 (en) | 2021-12-22 | 2023-06-29 | L'oreal | Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1339029C (en) * | 1988-06-20 | 1997-04-01 | Hiroyuki Kakoki | Transparent composition |
| US5510391A (en) * | 1993-10-22 | 1996-04-23 | Mayapple Holdings, Llc | Method of treating blood vessel disorders of the skin using vitamin K |
-
1997
- 1997-04-22 WO PCT/US1997/006464 patent/WO1997039746A1/en not_active Ceased
- 1997-04-22 AU AU28042/97A patent/AU2804297A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1997039746A1 (en) | 1997-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU4880197A (en) | Method for treatment of dermatological disorders | |
| AU8089494A (en) | Composition and method for treating blood vessel disorders of the skin using vitamin | |
| AU6974996A (en) | Compositions for the treatment of dermatological disorders and methods for their use | |
| AU6872498A (en) | Method and composition for skin treatment | |
| AUPM672594A0 (en) | A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders | |
| AU4216089A (en) | Method and composition for treating and preventing dry skin disorders | |
| AU3512295A (en) | Composition and method for treating hair | |
| AU5439996A (en) | Compositions and methods for treating pain | |
| AU2804297A (en) | Method of and composition for treating disorders of the skin using vitamin k | |
| AU2836499A (en) | Cosmetic method of treating skin | |
| AU3497097A (en) | Improved method for treatment and diagnosis of il-5 mediated disorders | |
| AU5774699A (en) | Human stearoyl-coa desaturase-related compositions and methods for treating skin disorders | |
| AU1714697A (en) | Method and composition for the treatment of osteoarthritis | |
| AU3768795A (en) | Method and compositions for hair treatment | |
| AU2251897A (en) | Method of treating liver disorders | |
| AU5198898A (en) | Method for treatment of glutamate related disorders | |
| AU3127795A (en) | Composition and treatment for baldness | |
| AU6165898A (en) | Method and apparatus for the treatment of strabismus | |
| AU2786197A (en) | Cosmetic method for treating and preventing the signs of skin ageing | |
| AUPN104895A0 (en) | Methods of and preparations for the treatment of ailments and disorders | |
| AU4717399A (en) | Method of treatment for dermatological disorders and compositions therefor | |
| AU1593697A (en) | Composition for treating skin affections and process for its preparation | |
| AU4027097A (en) | Method of treatment | |
| AU1282099A (en) | Method for treatment of disorders of attention | |
| AUPO372596A0 (en) | Composition and method for the prevention and treatment of skin disorders |